| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/04/2004 | CN1137122C Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensiv properties, process for their preparation and pharmaceutical compositions containing them |
| 02/04/2004 | CN1137118C Water soluble azoles as broad-spectrun antifungals |
| 02/04/2004 | CN1137100C Tricyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 02/04/2004 | CN1137098C New process for preparing pesticidal intermediates |
| 02/04/2004 | CN1137097C Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors |
| 02/04/2004 | CN1137088C Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine magnesium fumarate |
| 02/04/2004 | CN1137087C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/04/2004 | CN1137086C 2-aminopropane-1,3-diol compounds, medical use therof and intermediates in synthesizing the same |
| 02/04/2004 | CN1137083C New benzocyclobutane compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/04/2004 | CN1136919C Minoxidil compositions for external use |
| 02/04/2004 | CN1136909C Liniment 'Rubikang' and its preparing process |
| 02/04/2004 | CN1136904C Wound plaster of Yunnan Baiyao and its preparing method |
| 02/04/2004 | CN1136903C Shaddock-lozenge tablet and its producing method |
| 02/04/2004 | CN1136898C Burns treating ointment with functions of removing necrosis and promoting granulation |
| 02/04/2004 | CN1136895C Medicine for treating coronary heart disease |
| 02/04/2004 | CN1136887C Exterior-applied medicine for treating dermatopathy |
| 02/04/2004 | CN1136884C Diseases-resistant skin-protecting cream |
| 02/04/2004 | CN1136883C Ointment specially for treating dermatosis, preparing method thereof |
| 02/04/2004 | CN1136875C Chuqin Zihou San and its preparing process |
| 02/04/2004 | CN1136871C Traditional Chinese medicine for treating burn and scald and preparation process thereof |
| 02/04/2004 | CN1136866C External-use medicine for treating vaginitis |
| 02/04/2004 | CN1136864C Chinese medicine for treating mastoproliferation |
| 02/04/2004 | CN1136859C Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
| 02/04/2004 | CN1136857C Traditional Chinese medicine external preparation for curing piles |
| 02/04/2004 | CN1136856C Use of strontium salts for production of pharmaceutical compositions intended for treatment of arthrosis |
| 02/04/2004 | CN1136855C Cross-linked polymers for removing bile salts from patient |
| 02/04/2004 | CN1136854C Se-contained cyclodextrin and its application in preparing medicine to treat cataract |
| 02/04/2004 | CN1136853C Tablets containing 'beta'-lactam antibiotic and process for producing the same |
| 02/04/2004 | CN1136852C Pharmaceutical formulations of cefaclor |
| 02/04/2004 | CN1136851C Medicine for curing bronchial asthma and asthmatic chronic bronchitis and its preparing process |
| 02/04/2004 | CN1136850C Stable oral pharmaceutical composition containing substituted pyridylsulfinyl benzimidazole |
| 02/04/2004 | CN1136849C Gastric floating slow-releasing tinidazole capsule and its preparing method |
| 02/04/2004 | CN1136848C Application of bilirubin bitaurine sodium and its bilirubin derivative in preparing anti-HTV medicine |
| 02/04/2004 | CN1136847C Application of isogorgonian acid in pharmacy |
| 02/04/2004 | CN1136846C Formaldehyde injection for treating infective disease of animal |
| 02/04/2004 | CN1136845C 9-cis-visual yellow acid and use of its medicinal salt |
| 02/04/2004 | CN1136844C Anti-AIDS medicine composition and its application |
| 02/04/2004 | CN1136843C Transdermal therapeutic system containing estradiol |
| 02/04/2004 | CN1136839C Quick-acting ointment for treating dermatitis and eczema |
| 02/04/2004 | CN1136838C Solid, quick dissolving cetirizine fomulation |
| 02/04/2004 | CN1136832C Wrinkling modifiers |
| 02/04/2004 | CN1136792C Process for preparing additive rich in organic iodine compound from plant |
| 02/03/2004 | USRE38417 Secondary amines such as n1,n4-diethylspermine, used as insecticides, viricides, anticarcinogenic or antitumor agents and for therapy of psoriasis |
| 02/03/2004 | US6687428 Optical switch |
| 02/03/2004 | US6686493 Antiproliferation agent; antiinflammatory agents; side effect reduction |
| 02/03/2004 | US6686484 Anticoagulants; serine protease inhibitor |
| 02/03/2004 | US6686481 Highly purified simvastatin compositions |
| 02/03/2004 | US6686480 Psoralen compounds with aminoalkyl groups on the 5' position and optional alkyl groups on positions 4,4' and 8 that bind to nucleic acid of pathogens, and under photoactivation crosslink the nucleic acid, inactivating the pathogen |
| 02/03/2004 | US6686476 Substituted 1-aryl-3-heteroaryl-thioureas and substituted 1-aryl-3-heteroaryl-isothioureas as antiatherosclerotic agents |
| 02/03/2004 | US6686475 Compounds |
| 02/03/2004 | US6686470 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| 02/03/2004 | US6686467 Inhibitors of the production of cytokines such as tumour necrosis factor (hereinafter tnf), for example tnf alpha , and various members of the interleukin (hereinafter il) family, for example il-1, il-6 and il-8 |
| 02/03/2004 | US6686397 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 02/03/2004 | US6686394 Potent antineoplastic activity without systemic toxicity or mutagenicity |
| 02/03/2004 | US6686393 Pharmaceutical compositions having antiviral activity against human cytomegalovirus |
| 02/03/2004 | US6686391 N-(mono-, di- trichlorophenyl)carbamates, thiocarbamates or dithiocarbamates; anticarcinogenic agents; viricides; safer than adriamycin on healthy cells; effective against cells of moncytic linage infected with hiv |
| 02/03/2004 | US6686389 2,3-dihydrobenzofuran derivatives |
| 02/03/2004 | US6686388 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 02/03/2004 | US6686386 Combating photoinduced or chronological ageing of skin with retenoic acid receptor agonist |
| 02/03/2004 | US6686385 Anhydro sugar derivatives of indolocarbazoles |
| 02/03/2004 | US6686384 2-anilinophenyl-substituted; inhibition of the na+/h+ exchanger |
| 02/03/2004 | US6686383 Treatment of diabetic nephropathy with a biphenyl-4-yl)alkyl-1h-benzimidazole compounds |
| 02/03/2004 | US6686382 N-(isoxazolyl)thienylsulfonamides, n-(isoxazolyl)furylsulfonamides, n-(isoxazolyl)pyrrolylsulfonamides and n-(isoxazolyl)phenylsulfonamides; inhibit endothelin |
| 02/03/2004 | US6686381 Compounds that antagonize neuropeptide y at the y5 receptor subtype represent an approach to the treatment of eating disorders such as obesity and hyperphagia |
| 02/03/2004 | US6686380 For tumors that have initially been unresponsive to taxane therapy and developed drug resistance |
| 02/03/2004 | US6686379 Salt form of pantoprazole |
| 02/03/2004 | US6686378 Derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 02/03/2004 | US6686377 For therapy of pain |
| 02/03/2004 | US6686375 Composition useful as hepatoprotectants comprising extract of plant Cryptolepis buchanani and a method thereof |
| 02/03/2004 | US6686374 Azaindoles having serotonin receptor affinity |
| 02/03/2004 | US6686373 Analgesics; antiinflammatory agent |
| 02/03/2004 | US6686372 Selective β3 adrenergic agonists |
| 02/03/2004 | US6686371 Having an 11h-benzo(b)fluorene, an 11h-indeno-(1,2-b) quinoline, a benz(a)anthracene or analogous skeleton and an affinity for the estrogen receptor; contraceptives; menopausal complaints, osteoporosis; antitumor agents |
| 02/03/2004 | US6686370 8-(4,4-bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazospiro(4.5) decan-4-one, for example; treating pain with reduced side effects of opioid analgesics; affinity for opioid receptor-like (orl1) receptor |
| 02/03/2004 | US6686369 α-hydrdroxylic acid derivatives, their production and use |
| 02/03/2004 | US6686367 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 02/03/2004 | US6686366 Compounds specific to adenosine A3 receptor and uses thereof |
| 02/03/2004 | US6686363 Effective against multi-resistant bacteria |
| 02/03/2004 | US6686362 Indolinone derivatives |
| 02/03/2004 | US6686360 N-benzylpiperazine compounds |
| 02/03/2004 | US6686359 Growth hormone secretagogues |
| 02/03/2004 | US6686358 Anticoagulants; cardoviscular disorders |
| 02/03/2004 | US6686357 Benzimidazolo-piperidine compound |
| 02/03/2004 | US6686356 Pyridoquinoxaline antivirals |
| 02/03/2004 | US6686355 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686352 Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives |
| 02/03/2004 | US6686351 Compounds and methods for modulation of estrogen receptors |
| 02/03/2004 | US6686349 Administering to a patient for the treatment of sexual dysfunction an effective amount of substituted tetracyclic pyrroloquinolone derivatives |
| 02/03/2004 | US6686348 Metalloprotease inhibitors |
| 02/03/2004 | US6686347 Phthalazine derivatives for treating inflammatory diseases |
| 02/03/2004 | US6686346 Formulation |
| 02/03/2004 | US6686345 DNA-cleaving antitumor agents |
| 02/03/2004 | US6686341 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 02/03/2004 | US6686340 Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells |
| 02/03/2004 | US6686338 Enzyme inhibitors for metabolic redirection |
| 02/03/2004 | US6686337 Combination therapy comprising anti-diabetic and anticonvulsant agents |
| 02/03/2004 | US6686334 Decrease hyperalgesia, without impairing nociception |
| 02/03/2004 | US6686155 Treatment of tumor; obtain tissue sample, extract nucleotide sequences, amplify, detect preferential nucleotide sequences, incbate with antitumor agent, monitor sequence expression, adjustment in expression indicates effective antitumor agent |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |